Latest Ion Beam Applications S.A. Stories
Illinois Health and Science (IHS) announced that it has signed a definitive agreement to acquire IBA Molecular North America, Inc.
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) the leading global provider of PET radiopharmaceuticals, and NST (NeuroSurvival Technologies Ltd.) the leading developer of agents targeting apoptosis (programmed cell death) for molecular imaging and therapy, today announced the signing of a collaboration agreement for radiolabeling and distributing APOSENSE(R) [18F]-ML-10, NST's novel agent for molecular imaging of apoptosis, to sites participating in multi-center...
- a slit in a tire to drain away surface water and improve traction.